ATXS
Price
$4.40
Change
-$0.02 (-0.45%)
Updated
May 8 closing price
Capitalization
249.44M
94 days until earnings call
CABA
Price
$1.21
Change
+$0.05 (+4.31%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
58.86M
5 days until earnings call
Ad is loading...

ATXS vs CABA

Header iconATXS vs CABA Comparison
Open Charts ATXS vs CABABanner chart's image
Astria Therapeutics
Price$4.40
Change-$0.02 (-0.45%)
Volume$867.92K
Capitalization249.44M
Cabaletta Bio
Price$1.21
Change+$0.05 (+4.31%)
Volume$2.52K
Capitalization58.86M
ATXS vs CABA Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. CABA commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a StrongBuy and CABA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ATXS: $4.40 vs. CABA: $1.21)
Brand notoriety: ATXS and CABA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 211% vs. CABA: 58%
Market capitalization -- ATXS: $249.44M vs. CABA: $58.86M
ATXS [@Biotechnology] is valued at $249.44M. CABA’s [@Biotechnology] market capitalization is $58.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileCABA’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • CABA’s FA Score: 1 green, 4 red.
According to our system of comparison, CABA is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 3 TA indicator(s) are bullish while CABA’s TA Score has 4 bullish TA indicator(s).

  • ATXS’s TA Score: 3 bullish, 5 bearish.
  • CABA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CABA is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а -14.73% price change this week, while CABA (@Biotechnology) price change was -3.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +15.24%, and the average quarterly price growth was -12.41%.

Reported Earning Dates

ATXS is expected to report earnings on Aug 11, 2025.

CABA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($249M) has a higher market cap than CABA($58.9M). CABA YTD gains are higher at: -46.696 vs. ATXS (-50.783). ATXS (-111.56M) and CABA (-112.92M) have comparable annual earnings (EBITDA) . ATXS has more cash in the bank: 328M vs. CABA (183M). ATXS has less debt than CABA: ATXS (5.35M) vs CABA (15.2M). ATXS (0) and CABA (0) have equivalent revenues.
ATXSCABAATXS / CABA
Capitalization249M58.9M423%
EBITDA-111.56M-112.92M99%
Gain YTD-50.783-46.696109%
P/E RatioN/AN/A-
Revenue00-
Total Cash328M183M179%
Total Debt5.35M15.2M35%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSCABA
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 16 days ago
88%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBU22.310.98
+4.59%
Brookfield Business Partners LPLimited Partnership Units
GTLS157.426.68
+4.43%
Chart Industries
NSPR2.600.05
+1.96%
InspireMD
AUDC8.440.02
+0.24%
AudioCodes Ltd
TD63.05-0.08
-0.13%
Toronto Dominion Bank